The deadly cross-talk between Hippo pathway and epithelial–mesenchymal transition (EMT) in cancer

I Akrida, V Bravou, H Papadaki - Molecular Biology Reports, 2022 - Springer
Hippo signaling pathway is an evolutionarily conserved network that regulates organ size
growth and tissue regeneration. Hippo signaling dysfunction results in uncontrolled cell …

[HTML][HTML] The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment

Z Cao, L An, Y Han, S Jiao, Z Zhou - Acta Biochimica et Biophysica …, 2023 - ncbi.nlm.nih.gov
Gastric cancer (GC) is an aggressive malignant disease which still lacks effective early
diagnosis markers and targeted therapies, representing the fourth-leading cause of cancer …

Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression

XL Dou, FD Xia, XY Li - Epigenetics, 2023 - Taylor & Francis
The circular RNAs (circRNAs) involved in competitive endogenous RNA (ceRNA)
mechanism are critical modulators affecting pathogenesis of thyroid carcinoma (TC). The …

Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma

H Hu, Y Yin, B Jiang, Z Feng, T Cai, S Wu - Frontiers in Oncology, 2023 - frontiersin.org
Osteosarcoma (OS) is a cancer that is frequently found in children and adolescents and has
made little improvement in terms of prognosis in recent years. A recently discovered type of …

The influence of thyroid status, serum Tg, TSH, and TgAb on FNA‐Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma

J Sun, P Li, X Chen, Q Yu, L Li - Laryngoscope Investigative …, 2022 - Wiley Online Library
Objective Papillary thyroid carcinoma is treated in China mostly with surgery, including total
ablation, lobectomy, and lobe and isthmus resection. Therefore, whether thyroid status …

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling

M Wang, M Gao, Y Chen, J Wu, X Wang, Y Shu - BMC cancer, 2023 - Springer
Abstract Background Phospholipase C Delta 3 (PLCD3) is a member of phospholipase C
(PLC) Protein and PLCD3 protein plays a prominent role in many cancers. However, little is …

Dissecting the mechanism of action of spiperone—a candidate for drug repurposing for colorectal cancer

A Antona, M Varalda, K Roy, F Favero, E Mazzucco… - Cancers, 2022 - mdpi.com
Simple Summary Despite advances in primary and adjuvant treatments, approximately 50%
of colorectal cancer (CRC) patients still die from recurrence and metastatic disease. Thus …

Analysis of the regulatory role of miR-34a-5p/PLCD3 in the progression of osteoarthritis

P Ying, Y Xu, X Jiang, K Wang, Y Xue, Q Wang… - Functional & Integrative …, 2023 - Springer
Osteoarthritis is a heterogeneous disease with a complex etiology. However, there is no
effective treatment strategy at present. The purpose of this study was to explore the miRNA …

Identification and validation of a fatty acid metabolism gene signature for the promotion of metastasis in liver cancer

Z Zhang, J Sun, C Jin, L Zhang, L Wu… - Oncology …, 2023 - spandidos-publications.com
Metastasis is a fatal status for liver cancer, and the identification of an effective prediction
model and promising therapeutic target is essential. Given the known relationship between …

PLCD3 inhibits apoptosis and promotes proliferation, invasion and migration in gastric cancer

Y Yu, S Baral, Q Sun, J Ding, Q Zhang, F Zhao, S Gao… - Discover Oncology, 2024 - Springer
Gastric cancer (GC) is a heterogeneous disease whose development is accompanied by
alterations in a variety of pathogenic genes. The phospholipase C Delta 3 enzyme is a …